BioCyDex Inc.is a privately held, Edmonton-based spin-off company from the University of Alberta (Edmonton, AB). BioCyDex is currently developing a drug-delivery technology to distribute existing and novel anti-viral and chemotherapeutic compounds directly into cells, as well as a technology to deliver and image genes within a cell for use in gene therapy treatment.Company website does not exist.